SCHEMBL19334232

SCHEMBL19334232

CN(C)C(C(=O)C(C)(C)C)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
GAA P10253 1/20 0.50
ELOVL1 Q9BW60 1/20 0.44
HSP90AA1 P07900 1/20 0.42
MAPT P10636 1/20 0.42
GPR55 Q9Y2T6 1/20 0.42
AOC3 Q16853 1/20 0.42
KDM4E B2RXH2 2/20 0.41
ATM Q13315 2/20 0.41
CHRNB2 P17787 1/20 0.41
CHRNB4 P30926 1/20 0.41
CHRNA3 P32297 1/20 0.41
CHRNA4 P43681 1/20 0.41
MTOR P42345 1/20 0.41
CYP3A4 P08684 2/20 0.41
HIF1A Q16665 1/20 0.41
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
CYP2D6 P10635 1/20 0.39
SRC P12931 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8905685 1.00 ALDH1A1 (0.50) ALDH1A1GAAELOVL1HSP90AA1MAPT
SCHEMBL13224056 1.00 ALDH1A1 (0.50) ALDH1A1GAAELOVL1HSP90AA1MAPT
SCHEMBL20849994 0.85 ATM (0.43) ALDH1A1GAAELOVL1HSP90AA1MAPT
SCHEMBL19578343 0.85 ALDH1A1 (0.44) ALDH1A1GAAELOVL1AOC3KDM4E
SCHEMBL20849754 0.84 MTOR (0.41) ALDH1A1GAAHSP90AA1MAPTGPR55
SCHEMBL8910235 0.82 OPRM1 (0.43) ALDH1A1GAAHSP90AA1MAPTGPR55
SCHEMBL8908400 0.81 ALDH1A1 (0.44) ALDH1A1GAAAOC3CYP3A4
SCHEMBL8907267 0.81 CYP2C19 (0.36) ALDH1A1GAAELOVL1KDM4ECYP3A4
SCHEMBL10120515 0.81 ACP3 (0.41) ALDH1A1GAAMAPTAOC3MEN1
SCHEMBL14664133 0.81 ALDH1A1 (0.51) ALDH1A1GAAELOVL1HSP90AA1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9758487-B2 Hepatitis C virus inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2017-09-12 US disclosed